Executive Director, Therapeutic Area Strategy, Oncology and Hematology

Location: Cambridge MA, East Hanover NJ, US or Basel Switzerland. Hybrid working model.

About The Role

The Novartis Strategy & Growth, Therapeutic Area Strategy team for Oncology & Hematology is seeking an Executive Director, Therapeutic Area Strategy. This role will support:

• Creation and update of a holistic TA strategy
• Early-phase commercial insights to project teams
• TA-specific internal pipeline development and external licensing/acquisitions opportunities
• Integrated enterprise alignment across Biomedical Research (BR), Development, Strategy & Growth (S&G), and the Commercial US and International units

Responsibilities

• Brings external benchmarking, analysis, insights, and judgement to support the TA Strategy Head in developing a holistic Novartis TA strategy that achieves sustainable growth in short, mid, and long-term
• Applies understanding of the pharmaceutical industry and core Therapeutic Areas (TA) and Disease areas of Oncology & Hematology to derive insightful and differentiating competitive advantages
• Provides key commercial insights to R&D project teams, particularly for early phase programs (US in-market experience critical)
• Analyzes reports and publications to extract key messages, including building product forecasts
• Supports development and delivery of TA-specific strategic external insights to identify growth opportunities, emerging competitive challenges, and creation of a third-party view around key strategic levers; commissions targeted primary research

Requirements

• Bachelor’s degree required; advanced degree (PhD, MD, or other advanced University degree) and/or equivalent experience in life science/healthcare
• MBA, consulting, or equivalent experience highly preferred
• In-depth TA knowledge (or track record to acquire required TA expertise effectively and rapidly) in Oncology and/or Hematology
• Highly agile with capacity to support multiple strategic DAs within a TA and multiple programs (internal and external)
• Substantial experience evaluating new product opportunities (through M&A, BD&L, and internal research programs)
• 7–10 years of industry experience in pharma and/or medical devices in Research & Development and/or commercial functions, including conducting, commissioning, and analyzing primary research
• Experience in strategy development and asset shaping early in lifecycle (any functional perspective)
• Recent (post-2015) local US in-market experience, including working within the US market with local US customers and healthcare systems

Pay

The salary for this position is expected to range between $248,500 and $461,500 USD per year. The final salary offered is determined based on relevant skills and experience. Compensation includes a performance-based cash incentive and eligibility for annual equity awards.

Benefits

• Comprehensive health, life, and disability benefits
• 401(k) with company contribution and match
• Generous time off package including vacation, personal days, holidays, and other leaves